Skip to main content
. 2022 Feb 28;13(5):1540–1552. doi: 10.7150/jca.60124

Table 3.

Multivariate overall survival analysis of prognostic factors for lung adenocarcinoma patients (n=73)

Variable Overall survival
HR 95% CI P
Age (≤60 vs. >60 years) - - 0.140
Sex (male vs. female) - - 0.086
Smoking (no vs. yes) - - 0.928
Pathological stage (I/II vs. III) - - 0.090
Differentiation (poor/moderate vs. good) - - 0.714
miR-421 expression (low vs. high) 2.593 1.127-5.966 0.025

CI, confidence interval; HR, hazard ratio